Publisher
Springer Science and Business Media LLC
Reference7 articles.
1. Simon R. Sensitivity, specificity, PPV, and NPV for predictive biomarkers. JNCI J Natl Cancer Inst. 2015. https://doi.org/10.1093/jnci/djv153.
2. Huang Y, Gilbert PB, Janes H. Assessing treatment-selection markers using a potential outcomes framework. Biometrics. 2012;68(3):687–96.
3. Sitlani CM, Heagerty PJ. Analyzing longitudinal data to characterize the accuracy of markers used to select treatment. Stat Med. 2014;33(17):2881–96.
4. Colorectal cancer statistics. World cancer research fund. Undated. Available from https://www.wcrf.org/dietandcancer/cancer-trends/colorectal-cancer-statistics. Accessed 2 October 2020.
5. Cetuximab and panitumumab for previously untreated metastatic colorectal cancer, technology appraisal guidance [TA439] published 29 March 2017. Last updated 25 September 2017. Available from https://www.nice.org.uk/guidance/ta439. Accessed 2 October 2020.